We All Belong
2023 Diversity, Equity & Inclusion Impact Review
2023
Highlights
At Johnson & Johnson, we each have a responsibility to accelerate our progress with diversity, equity and inclusion (DEI). And we are all empowered to drive change within our company and the world at large.
-
$ 80 million
invested cumulatively by the end of 2023 in programs that provided vital health services and information to people of color through Our Race to Health Equity initiative
Learn more
Learn more -
9 countries
included in our pioneering approach to transgender clinical trial inclusion with our LIBERTAS oncology clinical study
Learn more
Learn more -
$ 11.9 million
awarded to 35 innovators developing health equity-focused solutions
Learn more
Learn more -
5 countries
assessed across 140 criteria in first-of-its-kind DEI Maturity pilot designed to enhance understanding of our DEI engagement and prioritize initiatives to enhance DEI impact in local markets
Learn more
Learn more -
24,800
employees engaged across 12 ERGs in 512 global chapters, leading a wide range of activities to advance DEI across all aspects of our organization and business
Learn more
Learn more -
$ 4.9 billion
Total Global Impact Spend representing addressable spend with small and diverse suppliers globally and small businesses in the U.S.
Learn more
Learn more
Awards &
recognition
Here are some of the ways we have been recognized for our DEI efforts. While we know there is more to do, we are proud of these accomplishments.
Click an
award for more
information